Document:

EX-10.6

 Exhibit 10.6 

Execution Version 

USHG Acquisition Corp. 

853 Broadway, 17th Floor 

New York, NY 10003 

January 6, 2021 
 USHG Investments, LLC 

853 Broadway, 17th Floor 
 New York, NY 10003 

 

	 	RE:	 Amendment No. 1 to Securities Subscription Agreement 

Ladies and Gentlemen: 
 THIS AMENDMENT NO. 1 TO
SECURITIES SUBSCRIPTION AGREEMENT (this “Amendment”) to that certain Securities Subscription Agreement, dated as of December 29, 2020 (the “Securities Subscription Agreement”), by and between USHG Acquisition Corp., a
Delaware limited liability company (the “Subscriber”), and USHG Investments, LLC, a Delaware corporation (the “Company”), is made as of January 6, 2021 by and among the Subscriber and the Company. Capitalized
terms used herein and not otherwise defined herein shall have the respective meanings ascribed to such terms in the Securities Subscription Agreement, as amended by this Amendment. 

WHEREAS, in accordance with Section 6.04 of the Securities Subscription Agreement, the terms of the Securities Subscription
Agreement may be modified or amended only by written agreement executed by the Subscriber and the Company; and  
 WHEREAS,
the Subscriber and the Company desire to amend the terms of the Securities Subscription Agreement in accordance with this Amendment. 

NOW, THEREFORE, in consideration of the mutual covenants and agreements set forth herein and for other good and valuable consideration,
the receipt and sufficiency of which are hereby acknowledged, the parties hereto agree as follows: 
  

	 	1.	 Forfeiture Mechanics. 

(a) The words “, up to 904,500 of which are subject to forfeiture by you if the underwriters of the initial public offering
(“IPO”) of units (“Units”) of the Company, do not fully exercise their over-allotment option (the “Over-allotment Option”)” are deleted from sentence two of the Preamble. 

(b) The words “, subject to forfeiture,” are deleted from sentence one of Section 1.01. 

(c) Article III is deleted in its entirety and the following is substituted in lieu thereof: 

“[Reserved.]” 

 2. Consent. The Company and the Subscriber each hereby consent to this Amendment in
accordance with Section 6.04 of the Securities Subscription Agreement. 
 3. Effect of Amendment. Except as specifically amended
herein, the Securities Subscription Agreement is hereby ratified and confirmed and shall remain in full force and effect. Each reference in the Securities Subscription Agreement to “this Agreement,” “hereunder,”
“hereof,” “herein” or words of like import, and each reference to the Securities Subscription Agreement in the other documents entered into in connection with the Securities Subscription Agreement, shall mean and be a reference
to the Securities Subscription Agreement, as amended by this Amendment. 
 4. Counterparts. This Amendment may be executed in one or
more counterparts, all of which when taken together shall be considered one and the same agreement and shall become effective when counterparts have been signed by each party and delivered to the other party, it being understood that both parties
need not sign the same counterpart. In the event that any signature is delivered by facsimile transmission or any other form of electronic delivery, such signature shall create a valid and binding obligation of the party executing (or on whose
behalf such signature is executed) with the same force and effect as if such signature page were an original thereof. 
 [Signature Page
Follows] 

  
 2 

 If the foregoing accurately sets forth our understanding and agreement, please sign the
enclosed copy of this Amendment and return it to us. 
  

			
	Very truly yours,
	
	USHG ACQUISITION CORP.
		
	By:	 	 /s/ Adam D. Sokoloff

	Name:	 	Adam D. Sokoloff
	Title:	 	Chief Executive Officer

 Accepted and agreed as of the date first written above. 

 

			
	USHG INVESTMENTS, LLC
	
	By: UNION SQUARE HOSPITALITY GROUP, LLC
		
	By:	 	 /s/ Avisheh Avini

	Name:	 	Avisheh Avini
	Title:	 	Chief Financial Officer

 [Signature Page to Amendment No. 1 to Securities Subscription Agreement]Exhibit
10.75

 

Employment
Agreement

Vinco-Ferguson

 

This
EMPLOYMENT AGREEMENT (the “Agreement”), is entered into as of February 2, 2021, by and between Vinco Ventures,
Inc., a Nevada corporation (the “Company”), and Christopher Ferguson (the “Executive”).

 

WHEREAS,
the effectiveness date of this agreement is November 12, 2020 at the closure of the Vinco Ventures Merger;

 

WHEREAS,
the Company recognizes that the Executive has had and is expected to continue to have a critical and essential role in guiding
the Company and in developing the Company’s business;

 

WHEREAS,
the Executive is expected to make major contributions to the stability, growth and financial strength of the Company;

 

WHEREAS,
the Company has determined that appropriate arrangements should be taken to encourage the continued attention and dedication of
the Executive to his assigned duties without distraction;

 

WHEREAS,
in consideration of the Executive’s employment with the Company, the Company desires to provide the Executive with certain
compensation and benefits as set forth in this Agreement;

 

WHEREAS,
as of the date of this Agreement, the Company wishes to continue Executive’s service as a Chief Executive Officer under
the terms of an employment agreement on the terms set forth herein, which shall supersede all previous agreements regarding Executive’s
employment by the Company; and

 

WHEREAS,
the Executive desires to be employed by the Company on the terms contained in this Agreement.

 

NOW,
THEREFORE, in consideration of the mutual covenants and agreements herein contained and other good and valuable consideration,
the receipt and sufficiency of which is hereby acknowledged, the parties agree as follows:

 

1.
Position and Duties.

 

(a)
The Executive shall serve as the Chief Executive Officer of the Company reporting to the Company’s Board of Directors (the
“Board”). The Executive shall primarily work from the Corporate Headquarters located at 1 West Broad Street,
Suite 1004, Bethlehem PA 18018 or at other locations as may be determined by the Executive. (the “Executive’s Office”).

 

(b)
Without further compensation, the Executive may serve as a director or officer of one or more of the Company’s subsidiaries
or affiliates if so elected or appointed from time to time.

 

(c)
The Executive shall have such duties, authority and responsibilities as are consistent with the role of Chief Executive Officer
and as may be set forth in the Bylaws of the Company. Roles and Responsibilities include but are not limited to capital raises,
investor relations and overall corporate guidance. For purposes of the applicability of the Company compensation plans to the
Executive, Executive shall be considered an “employee.” Executive shall devote a substantial amount of his business
time to the performance of his duties hereunder, but such requirement shall not prevent Executive from (i) serving as a member
of the board of directors of unaffiliated companies, (ii) serving on civic, charitable, educational, religious, public interest
or public service boards, (iii) managing the Executive’s personal and family investments, and (iv) engaging in or having
an ownership interest in other businesses. In addition, the Executive has disclosed, in writing, to the Company his involvement
in entities and investments other than the Company (collectively, the “Outside Activities”). The Company shall
permit the Executive to continue to engage in the Outside Activities provided that the Executive agrees to disclose to the Board,
in writing, any actual or potential conflict of interest arising out of any such Outside Activity and no such Outside Activity
materially interferes with Executive’s ability to perform his responsibilities hereunder.

 

    	1

    	 

    

 

2.
Term. This Agreement and Executive’s employment hereunder shall be for an initial term of three (3) years commencing
on the date hereof (the “Effective Date”) and ending on the third anniversary of the Effective Date (the “Expiration
Date”), unless terminated earlier by the Company or the Executive pursuant to Section 4 of this Agreement (the “Term”).
Thereafter, this Agreement shall automatically be renewed and the Term shall be extended for additional consecutive terms of 1
year (each a “Renewal Term”), unless such renewal is objected to by either the Company or the Executive upon
90 days written notice prior to the commencement of the next Renewal Term. In the event of renewal, the last day of each Renewal
Term shall be deemed the new Expiration Date.

 

3.
Compensation and Related Matters.

 

(a)
Base Salary. The Executive’s initial annual base salary shall be $200,000, less applicable withholdings (the “Base
Salary”) and 120,000 common shares that shall vest in their entirety on issuance. The Base Salary shall be payable in
accordance with the Company’s normal payroll procedures in effect from time to time. The Base Salary due of shares, shall
be payable within the first 30 days of the year. On each anniversary of this Agreement the base salary will increase no less than
$15,000 (“minimum”). The Board shall review the Base Salary annually and may increase the Base.

 

(b)
Annual Bonus. For 2021, Executive shall receive a cash bonus in the amount equal to 30% of the annual Base Salary, and
an award of 200% shares of Company common stock, which shall vest in their entirety on issuance (the “Principal Market”),
which shall be received by the Executive no later than the first 30 days of the current fiscal year. After 2021 and during the
Term, the Executive will receive an annual cash bonus and an annual award of shares of common stock, subject to vesting conditions,
in respect of each full or partial fiscal year of the Company, as well as other cash or equity bonuses, as determined in the sole
discretion of the Board based on its assessment of Company and individual performance in relation to performance targets, a subjective
evaluation of Executive’s performance or such other criteria as may be established by the Board (the “Annual Bonus”).
The Annual Bonus will be paid no later than the 75th day following the end of the fiscal year to which the Annual Bonus
relates. The annual cash target bonus is 25% of the Base Salary and the value of the annual award of shares of Company common
stock, as of the date of the grant, will be equal to 200% of the Base Salary as determined by the closing price of the common
stock on the Principal Market on the date of grant (which shares of common stock shall vest ratably at the end of each of the
six calendar quarters subsequent to the calendar quarter in which the grant is made). Any award of common stock pursuant to this
Agreement shall be subject to the Company’s receipt of all corporate approvals required by applicable law or the rules and
regulation of the Principal Market and the terms of a Restricted Stock Award Agreement between Executive and the Company to be
agreed upon following the execution of this Agreement and prior the issuance of any common stock award to the Executive (each,
an “Award Agreement”).

 

(c)
Past Performance Bonus. Upon the execution of this agreement, the Executive is entitled to a one-time past performance
bonus for the work completed in fiscal years 2018, 2019 and 2020 of 200,000 shares of Company common stock, which shall vest in
their entirety on issuance.

 

(d)
Enterprise Value Incentive Bonus. The Executive shall be entitled to 150,000 shares of Company common stock, due immediately
upon an increase of 2.5 times the Enterprise Value on a 5-day closing average from the effectiveness of this agreement. For clarification,
the Enterprise Value as of the Company at the effective date was

$25,042,464.

 

(e)
Business Expenses. The Company shall promptly reimburse the Executive for all reasonable and necessary business-related
expenses incurred in connection with the performance of the Executive’s duties hereunder in accordance with the policies
and procedures then in effect and established by the Company for its senior executive officers, provided that the Executive furnishes
the Company with all supporting information and documentation relevant to such expenses as the Company may reasonably request.
The Executive is entitled, though not required, to travel first class or business class on all domestic and international flights
longer than three hours.

 

(f)
Health Insurance. Executive shall be entitled to participate in any Company health insurance plan on the same terms and
conditions as other Company senior executives are permitted to participate.

 

(g)
Life Insurance. To the extent practicable, the Company shall, during the Term, pay the premiums of a life insurance policy,
providing coverage in the amount of $3,000,000, payable to a beneficiary chosen by Executive, which insures the life of Executive.
Executive shall provide all information and cooperation reasonably necessary to obtain such life insurance policy.

 

    	2

    	 

    

 

(h)
Other Benefits. The Executive shall be entitled to participate in all pension, savings and retirement plans, welfare and
insurance plans, practices, policies, programs and perquisites of employment applicable generally to other senior executives of
the Company. The Executive shall be entitled to participate in all stated Company reimbursement plans.

 

(i)
Paid Time Off. The Executive shall be entitled to accrue up to 20 paid leave days in each year, which shall be accrued
ratably. The Executive shall also be entitled to all paid holidays given by the Company to its executives and employees. Any unused
paid leave days shall be rolled forward to be used in future years, provided that paid leave days shall not accrue further if
Executive has 30 accrued but unused paid leave days.

 

(j)
Withholding. All amounts payable to the Executive under this Section 3 shall be subject to all required federal, state
and local withholding, payroll and insurance taxes and requirements.

 

4.
Termination.

 

(a)
Death. The Executive’s employment hereunder shall terminate upon his death.

 

(b)
Disability. The Company may terminate the Executive’s employment if the Executive becomes subject to a Disability.
For purposes of this Agreement, “Disability” means the Executive is unable to perform the essential functions
of his position as CEO, with or without a reasonable accommodation, for a period of 120 consecutive days or 180 days during any
rolling consecutive 12-month period.

 

(c)
Termination by Company for Cause. The Company may terminate the Executive’s employment for Cause. For purposes of
this Agreement, “Cause” means the Executive’s: (i) willful misconduct, gross negligence, fraud, embezzlement
or other material dishonesty with respect to the affairs of the Company or any of its affiliates; (ii) material failure to meet
minimum performance expectations of the Board; (iii) conviction, plea of nolo contendere, guilty plea, or confession to
either a felony or any lesser crime relating to the affairs of the Company or any of its affiliates or of which fraud, embezzlement,
or moral turpitude is a material element; or (iv) a material breach of this Agreement or a breach of a fiduciary duty owed to
the Company, provided that any such breach, if curable, shall not constitute Cause unless the Company has provided the Executive
with (x) written notice of the acts or omissions giving rise to a termination of his employment for Cause; (y) the opportunity
to correct the act or omission within 30 days after receiving the Company’s notice (the “Cure Period”);
and (z) an opportunity to be heard before the Board with the Executive’s counsel present prior to the expiration of the
Cure Period.

 

(d)
Termination by the Company without Cause. The Company may not terminate the Executive’s employment during any Term
or Renewal Term without Cause.

 

(e)
Termination by the Executive. The Executive may terminate his employment at any time for any reason other than a Good Reason,
upon 30 days prior written notice.

 

(f)
Termination by the Executive for Good Reason. The Executive may terminate his employment for Good Reason by providing written
notice. For purposes of this Agreement, “Good Reason” means: (i) a material reduction in the Executive’s
Base Salary; (ii) a material diminution in the Executive’s responsibilities as CSO; (iii) the assignment of duties to the
Executive materially inconsistent with his position as CSO; (iv) the requirement that the Executive relocate his primary place
of employment more than 50 miles from Executive’s Office (unless such location is closer to the Executive’s primary
residence); (v) any person or entity or group becoming the beneficial owner, directly or indirectly, of securities of the Company
representing more than 50% of the total voting power of all its then outstanding voting securities, (vi) a merger of consolidation
of the Company in which its voting securities immediately prior to the merger or consolidation do not represent, or are not converted
into securities that represent, a majority of the voting power of all voting securities of the surviving entity immediately after
the merger or consolidation, a sale of substantially all of the assets of the Company or a liquidation or dissolution of the Company;
(vii) individuals who, as of the signing of this Agreement, constitute the Board of Directors (the “Incumbent Board”)
cease for any reason to constitute at least a majority of such Board; or (viii) individuals who, as of the signing of this Agreement,
constitute the C-suite of the company (the “Incumbent Management”) cease for any reason to constitute at least a majority
of such Management; (iv) the Company’s material breach of this Agreement; provided that Good Reason based on a material
breach shall exist only if within 90 days of the Company’s act or omission resulting in a material breach, the Executive
notifies the Company in a writing of the act or omission, the Company fails to correct the act or omission within 30 days after
receiving the Executive’s written notice and the Executive actually terminates his employment within the 30 days following
the end of such 30-day cure period.

 

    	3

    	 

    

 

(g)
Expiration. Executive’s employment shall terminate on the Expiration Date.

 

(h)
Termination Date. The “Termination Date” means: (i) if the Executive’s employment is terminated
by his death under Section 4(a), the date of his death; (ii) if the Executive’s employment is terminated on account of his
Disability under Section 4(b), the date on which the Company provides the Executive a written termination notice; (iii) if the
Company terminates the Executive’s employment for Cause under Section 4(c), the date on which the Company provides the Executive
a written termination notice, unless the circumstances giving rise to the termination are subject to the Cure Period, in which
case the date on which the Company provides the Executive a written termination notice following the end of the Cure Period; (iv)
if, despite the restriction against doing so under Section 4(d), the Company terminates the Executive’s employment without
Cause under Section 4(d), 90 days after the date on which the Company provides the Executive a written termination notice; (v)
if the Executive resigns his employment without Good Reason under Section 4(e), 30 days after the date on which the Executive
provides the Company a written termination notice; (vii) if the Executive resigns his employment with Good Reason under Section
4(f), the date on which the Executive provides the Company a timely written termination notice, except the Termination Date shall
be the last day of the relevant 30-day cure period, if applicable; and (viii) the Expiration Date if the Executive’s employment
terminates under Section 4(g).

 

5.
Compensation upon Termination.

 

(a)
Termination by the Company for Cause; by the Executive without Good Reason; or upon the Expiration Date following the Executive’s
election not to Renew. If the Executive’s employment with the Company is terminated pursuant to Section 4(c), 4(e),
or 4(g), the Company shall pay or provide to the Executive the following amounts through the applicable Termination Date: any
earned but unpaid Base Salary, unpaid expense reimbursements, any earned but unpaid Annual Bonus, and the value of any accrued
and unused vacation days (the “Accrued Obligations”) on or before the time required by law but in no event
more than 30 days after the Executive’s Termination Date.

 

(b)
 Disability. If the Executive’s employment terminates because of his Disability as provided in Section 4(b), then
the Executive (or his authorized representative or estate) shall be entitled to the following:

 

(i)
the Accrued Obligations earned through the applicable Termination Date (payable on or before the time required by law but in no
event more than 30 days after the applicable Termination Date);

 

(ii)
a pro-rata portion of the Executive’s Annual Bonus, if any, for the fiscal year in which the Executive’s termination
occurs (determined by multiplying the amount of such bonus which would be due for the full fiscal year by a fraction, the numerator
of which is the number of days during the fiscal year of termination that the Executive is employed by the Company and the denominator
of which is 365) payable at the same time bonuses for such year are paid to other senior executives of the Company;

 

(iii)
vest the Executive on the applicable Termination Date for any and all previously granted outstanding equity-incentive awards subject
to time-based vesting criteria as if the Executive continued to provide services to the Company for 12 months following the applicable
Termination Date;

 

(iv)
Subject to the Executive’s or, in the event of his death, his eligible dependents’ timely election of
continuation coverage under the Consolidated Omnibus Budget Reconciliation Act of 1985, as amended
(“COBRA”), the Company shall reimburse the Executive or his eligible dependents the monthly premium
payable to continue his and his eligible dependents’ participation in the Company’s group health plan (to the
extent permitted under applicable law and the terms of such plan) which covers the Executive (and the Executive’s
eligible dependents) for a period of twelve (12) months, provided that the Executive is eligible and remains eligible
for COBRA coverage; and provided, further, that in the event that the Executive obtains other employment that
offers group health benefits, such continuation of coverage by the Company shall immediately cease. If the reimbursement of
any COBRA premiums would violate the nondiscrimination rules or cause the reimbursement of claims to be taxable under the
Patient Protection and Affordable Care Act of 2010, together with the Health Care and Education Reconciliation Act of 2010
(collectively, the “Act”) or Section 105(h) of the Internal Revenue Code (the “Code”), the
Company paid premiums shall be treated as taxable payments and be subject to imputed income tax treatment to the extent
necessary to eliminate any discriminatory treatment or taxation under the Act or Section 105(h) of the Code; and

 

    	4

    	 

    

 

(v)
in the case of a termination due to Disability, in addition to the aforementioned awards, continuation of the Base Salary in effect
on the Termination Date until the earlier of (A) the 12 month anniversary of the Termination Date, and (B) the date Executive
is eligible to commence receiving payments under the Company’s long-term disability policy. If the net compensation from
the Base Salary is greater than the net compensation from the long-term disability policy, the Company, through the 12 month anniversary
of the Termination Date will compensate the Executive’s estate the difference in net compensation.

 

(c)
Termination by the Company without Cause, by the Executive with Good Reason or death. If the Executive’s employment
is terminated by the Company without Cause despite the restriction against doing so under Section 4(d), or the Executive terminates
his employment for Good Reason as provided in Section 4(f), then the Executive shall, except to the extent Section 5(d) is applicable,
be entitled to the following:

 

(i)
the Accrued Obligations earned through the applicable Termination Date (payable on or before the time required by law but in no
event more than 30 days after the applicable Termination).

 

(ii)
severance in a single lump sum installment in an (A) amount equal to 1.5x the sum of the Base Salary at the rate in effect on
the Termination Date, plus (B) an amount equal to 2x the maximum Annual Bonus for which the Executive is eligible in the fiscal
year in which the Termination Date occurs, or if, there is no Annual Bonus for which he is eligible in the fiscal year in which
the Termination Date occurs, 2x the Annual Bonus most recently issued to the Executive, plus (C) an 50,000 common shares. The
severance is payable no later than 30 days following the applicable Termination Date.

 

(iii)
A pro-rata portion of the Executive’s Annual Bonus, if any, for the fiscal year in which the Executive’s termination
occurs (determined by multiplying the amount of such bonus which would be due for the full fiscal year by a fraction, the numerator
of which is the number of days during the fiscal year of termination that the Executive is employed by the Company and the denominator
of which is 365 payable at the same time bonuses for such year are paid to other senior executives of the Company.

 

(iv)
full vesting of the Executive in any and all previously granted outstanding equity-based incentive awards subject to time-based
vesting criteria.

 

(v)
Subject to the Executive’s timely election of continuation coverage under COBRA, the Company shall reimburse the Executive
the monthly premium payable to continue his and his eligible dependents’ participation in the Company’s group health
plan (to the extent permitted under applicable law and the terms of such plan) which covers the Executive (and the Executive’s
eligible dependents) for a period of 12 months, provided that the Executive is eligible and remains eligible for COBRA
coverage; and provided, further, that in the event that the Executive obtains other employment that offers group
health benefits, such continuation of coverage by the Company shall immediately cease. If the reimbursement of any COBRA premiums
would violate the nondiscrimination rules or cause the reimbursement of claims to be taxable under the Act or Section 105(h) of
the Code, the Company paid premiums shall be treated as taxable payments and be subject to imputed income tax treatment to the
extent necessary to eliminate any discriminatory treatment or taxation under the Act or Section 105(h) of the Code.

 

(d)
Change of Control: For purposes of Section 5(d), a change of control shall have occurred upon any of the following:

(i)
any person or entity or group becoming the beneficial owner, directly or indirectly, of securities of the Company representing
more than 50% of the total voting power of all its then outstanding voting securities;

 

    	5

    	 

    

 

(ii)
a merger or consolidation of the Company in which its voting securities immediately prior to the merger or consolidation do not
represent, or are not converted into securities that represent, a majority of the voting power of all voting securities of the
surviving entity immediately after the merger or consolidation;

 

(iii)
a sale of substantially all of the assets of the Company or a liquidation or dissolution of the Company; or

 

(iv)
individuals who, as of the date of the signing of this Agreement, constitute the Board of Directors (the “Incumbent Board”)
cease for any reason to constitute at least a majority of such Board; provided that any individual who becomes a director of the
Company subsequent to the date of the signing of this Agreement, whose election, or nomination for election by the Company stockholders,
was approved by the vote of at least a majority of the directors then in office shall be deemed a member of the Incumbent Board.

 

(e)
Consequence of a Change in Control. Notwithstanding the terms of any employee compensation plan, if, as of the date of
a Change in Control, Executive holds equity awards issued under such a plan that are not vested and, if applicable, exercisable,
such equity awards shall become fully vested and, if applicable, exercisable, as of the date of the Change in Control if the acquirer
does not agree to assume or substitute for equivalent equity awards such outstanding unvested equity awards.

 

(f)
No Mitigation or Offset. In the event of any termination of Executive’s employment hereunder, Executive shall be
under no obligation to seek other employment or otherwise mitigate the obligations of the Company under this Agreement, and there
shall be no offset against any amounts due under this Agreement on account of any remuneration attributable to any subsequent
employment that Executive may obtain.

 

(g)
Effect of Termination on Officer and Board Positions. Any termination of the Executive with respect to the Executive’s
standing as an executive officer or Board Member must expressly designate which such role is subject to termination. The termination
of the Executive as an Officer will not thereby terminate the Executive’s Board status unless the termination so states,
in which event the Executive shall resign his Board position as a condition to receiving any of the payments set forth in this
Section 5.

 

6.
Section 409A Compliance.

 

(a)
All in-kind benefits provided and expenses eligible for reimbursement under this Agreement shall be provided by the Company or
incurred by the Executive during the time periods set forth in this Agreement. All reimbursements shall be paid as soon as administratively
practicable, but in no event shall any reimbursement be paid after the last day of the taxable year following the taxable year
in which the expense was incurred. The amount of in-kind benefits provided or reimbursable expenses incurred in one taxable year
shall not affect the in-kind benefits to be provided or the expenses eligible for reimbursement in any other taxable year. Such
right to reimbursement or in-kind benefits is not subject to liquidation or exchange for another benefit.

 

(b)
To the extent that any of the payments or benefits provided for in Section 5(b), (c) or (d) are deemed to constitute non-qualified
deferred compensation benefits subject to Section 409A of the United States Internal Revenue Code (the “Code”),
the following interpretations apply to Section 5:

 

(i)
Any termination of the Executive’s employment triggering payment of benefits under Section 5(b), (c) or (d) must
constitute a “separation from service” under Section 409A(a)(2)(A)(i) of the Code and Treas. Reg.
§1.409A-1(h) before distribution of such benefits can commence. To the extent that the termination of the
Executive’s employment does not constitute a separation of service under Section 409A(a)(2)(A)(i) of the Code and
Treas. Reg. §1.409A-1(h) (as the result of further services that are reasonably anticipated to be provided by the
Executive to the Company or any of its parents, subsidiaries or affiliates at the time the Executive’s employment
terminates), any benefits payable under Section 5(b), (c) or (d) that constitute deferred compensation under Section
409A of the Code shall be delayed until after the date of a subsequent event constituting a separation of service under
Section 409A(a)(2)(A)(i) of the Code and Treas. Reg. §1.409A-1(h). For purposes of clarification, this Section 6(b)(i)
shall not cause any forfeiture of benefits on the Executive’s part but shall only act as a delay until such time as a
“separation from service” occurs.

 

    	6

    	 

    

 

(ii)
If the Executive is a “specified employee” (as that term is used in Section 409A of the Code and regulations and other
guidance issued thereunder) on the date his separation from service becomes effective, any benefits payable under Section 5(b),
(c) or (d) that constitute non-qualified deferred compensation under Section 409A of the Code shall be delayed until the earlier
of (A) the business day following the six-month anniversary of the date his separation from service becomes effective, and (B)
the date of the Executive’s death, but only to the extent necessary to avoid such penalties under Section 409A of the Code.
On the earlier of (A) the business day following the six-month anniversary of the date his separation from service becomes effective,
and (B) the Executive’s death, the Company shall pay the Executive in a lump sum the aggregate value of the non-qualified
deferred compensation that the Company otherwise would have paid the Executive prior to that date under Section 5(b), (c) or (d)
of this Agreement.

 

(iii)
It is intended that each installment of the payments and benefits provided under Section 5(b), (c) or (d) of this Agreement shall
be treated as a separate “payment” for purposes of Section 409A of the Code.

 

(iv)
Neither the Company nor the Executive shall have the right to accelerate or defer the delivery of any such payments or benefits
except to the extent specifically permitted or required by Section 409A of the Code.

 

7.
Excess Parachute Payments.

 

(a)
To the extent that any payment, benefit or distribution of any type to or for the benefit of the Executive by the Company or any
of its affiliates, whether paid or payable, provided or to be provided, or distributed or distributable pursuant to the terms
of this Agreement or otherwise (including, without limitation, any accelerated vesting of stock options or other equity-based
awards) (collectively, the “Total Payments”) would be subject to the excise tax imposed under Section 4999
of the Internal Revenue Code of 1986, as amended (the “Code”), then the Total Payments shall be reduced (but
not below zero) so that the maximum amount of the Total Payments (after reduction) shall be one dollar ($1.00) less than the amount
which would cause the Total Payments to be subject to the excise tax imposed by Section 4999 of the Code, but only if the Total
Payments so reduced result in the Executive receiving a net after tax amount that exceeds the net after tax amount the Executive
would receive if the Total Payments were not reduced and were instead subject to the excise tax imposed on excess parachute payments
by Section 4999 of the Code. Unless the Executive shall have given prior written notice to the Company to effectuate a reduction
in the Total Payments if such a reduction is required, any such notice consistent with the requirements of Section 409A of the
Code to avoid the imputation of any tax, penalty or interest thereunder, the Company shall reduce or eliminate the Total Payments
by first reducing or eliminating any cash severance benefits (with the payments to be made furthest in the future being reduced
first), then by reducing or eliminating any accelerated vesting of stock options or similar awards, then by reducing or eliminating
any accelerated vesting of restricted stock or similar awards, then by reducing or eliminating any other remaining Total Payments.
The preceding provisions of this Section 7(a) shall take precedence over the provisions of any other plan, arrangement or agreement
governing the Executive’s rights and entitlements to any benefits or compensation.

 

(b)
If the Total Payments to the Executive are reduced in accordance with Section 7(a), as a result of the uncertainty in the
application of Section 4999 of the Code at the time of the initial reduction under Section 7(a), it is possible that Total
Payments to the Executive which will not have been made by the Company should have been made
(“Underpayment”) or that Total Payments to the Executive which were made should not have been made
(“Overpayment”). If an Underpayment has occurred, the amount of any such Underpayment shall be promptly
paid by the Company to or for the benefit of the Executive. In the event of an Overpayment, then the Executive shall promptly
repay to the Company the amount of any such Overpayment together with interest on such amount (at the same rate as is
applied to determine the present value of payments under Section 280G of the Code or any successor thereto), from the date
the reimbursable payment was received by the Executive to the date the same is repaid to the Company

 

    	7

    	 

    

 

8.
Confidentiality and Restrictive Covenants.

 

(a)
Covenant Against Disclosure. All Confidential Information (defined below) relating to the Business of the Company and its
affiliates is, shall be and shall remain the sole property and confidential business information of them, free of any rights of
the Executive. The Executive shall not make any use of the Confidential Information except in the performance of his duties hereunder
and shall not disclose any Confidential Information or trade secret to third parties except as required by law, with the limited
qualification that in accordance with the Defend Trade Secrets Act of 2016, an individual shall not be held criminally or civilly
liable under any Federal or State trade secret law for the disclosure of a trade secret that is made either: (1) in confidence
to a Federal, State, or local government official, either directly or indirectly, or to an attorney, solely for the purpose of
reporting or investigating a suspected violation of law; or (2) in a complaint or other document filed in a lawsuit or other proceeding,
if such filing is made under seal, “Confidential Information” includes without limitation such documents as business
plans, source code, documentation, financial analysis, marketing plans, customer names, customer lists, customer data, contracts
and other business information, including the information of the Company and its affiliates, existing or prospective customers,
clients, investors or other third parties with whom the Company and its affiliates hereto have relationships or conduct business
that may be disclosed to the Executive as part of the Executive’s employment. Notwithstanding anything else set forth herein,
nothing in this Agreement shall be construed to prohibit Executive from reporting, without first notifying the Company or otherwise,
possible violations of law or regulation to any governmental agency or entity.

 

(b)
Return of Company Documents. On the Termination Date or on any prior date upon the Company’s written demand, the
Executive will return all Confidential Information in his possession, directly or indirectly, that is in written or other tangible
form (together with all duplicates thereof).

 

(c)
Further Covenant. During the Term and through the first anniversary of the Termination Date, the Executive shall not, directly
or indirectly, take any of the following actions, and, to the extent the Executive owns, manages, operates, controls, is employed
by or participates in the ownership, management, operation or control of, or is connected in any manner with, any business, the
Executive will use his best efforts to ensure that such business does not take any of the following actions:

 

(i)
persuade or attempt to persuade any customer of the Company or its affiliates to cease doing business with the Company or its
affiliates, or to reduce the amount of business any customer does with the Company or its affiliates;

 

(ii)
solicit for himself or any entity the business of a person or entity that was a customer of the Company or its affiliates within
the 12 months prior to the termination of the Executive’s employment, in competition with the Company or its affiliates;
or

 

(iii)
persuade or attempt to persuade any employee of the Company or its affiliates to leave the employ of the Company or its affiliates,
or hire or engage, directly or indirectly, any individual who was an employee of the Company or its affiliates within 1 year prior
to the Executive’s Termination Date.

 

9.
D&O Insurance. At the request of the Executive, the Company obtain and continue for as long as Executive is employed
by the Company, directors’ and officers’ insurance coverage at levels no less than $5,000,000 with an insurance company
rated “A” or higher.

 

    	8

    	 

    

 

10. Waiver.
Except with respect to opportunities in which the Company would be interested in the ordinary course of its business and
which are presented to the Executive in his capacity as a director or executive officer of the Company, the Board has
renounced on behalf of the Company and its shareholders all interest and expectancy to (or being offered any opportunity to
participate in) any opportunity presented to the Executive that may be considered a corporate opportunity of the Company, and
the Executive shall have no obligation to communicate, offer, or present any opportunity presented to the Executive that may
be considered a corporate opportunity of the Company, whether centered on geography, land rights, or otherwise (the
“Renouncement”). The Company acknowledges that the Renouncement is a material term of this Agreement and
the Executive is specifically relying on the Renouncement in agreeing to enter into this Agreement. Except with respect to
opportunities in which the Company would be interested in the ordinary course of its business and which are presented to the
Executive in his capacity as a director or executive officer of the Company, to the fullest extent permitted by law, the
Company hereby prospectively waives any and all claims arising from any business transacted by the Executive that could be
construed as a corporate opportunity of the Company. A copy of the Board resolution is attached hereto as Exhibit
B.

 

11.
No Disparagement. During the Term and through the second anniversary of the Termination Date, the Executive will not make
public statements or communications that disparage the Company or any of its businesses, services, products, affiliates or current,
former or future directors and executive officers in their capacity as such. During the Term and through the second anniversary
of the Termination Date, the Company will instruct its directors and executives not to make public statements or communications
that disparage the Executive. The foregoing obligations shall not be violated by truthful statements to any governmental agency
or entity, required governmental testimony or filings, or administrative or arbitral proceedings (including, without limitation,
depositions in connection with such proceedings).

 

12.
Indemnification. During the Term and thereafter, the Company shall indemnify and hold the Executive and the Executive’s
heirs and representatives harmless, to the maximum extent permitted by law, against any and all damages, costs, liabilities, losses
and expenses (including reasonable attorneys’ fees) as a result of any claim or proceeding (whether civil, criminal, administrative
or investigative), or any threatened claim or proceeding (whether civil, criminal, administrative or investigative), against the
Executive that arises out of or relates to the Executive’s service as an officer, director or employee, as the case may
be, of the Company, or the Executive’s service in any such capacity or similar capacity with any affiliate of the Company
or other entity at the Company’s request, both prior to and after the Effective Date, and to promptly advance to the Executive
or the Executive’s heirs or representatives such expenses, including litigation costs and attorneys’ fees, upon written
request with appropriate documentation of such expense upon receipt of an undertaking by the Executive or on the Executive’s
behalf to repay such amount if it shall ultimately be determined that the Executive is not entitled to be indemnified by the Company.
During the Term and thereafter, the Company also shall provide the Executive with coverage under its then current directors’
and officers’ liability policy to the same extent that it provides such coverage to its other executive officers. If the
Executive has any knowledge of any actual or threatened action, suit or proceeding, whether civil, criminal, administrative or
investigative, as to which the Executive may request indemnity under this provision, the Executive will give the Company prompt
written notice thereof; provided that the failure to give such notice shall not affect the Executive’s right to indemnification.
The Company shall be entitled to assume the defense of any such proceeding and the Executive will use reasonable efforts to cooperate
with such defense. To the extent that the Executive in good faith determines that there is an actual or potential conflict of
interest between the Company and the Executive in connection with the defense of a proceeding, the Executive shall so notify the
Company and shall be entitled to separate representation at the Company’s expense by counsel selected by the Executive (provided
that the Company may reasonably object to the selection of counsel within 10 business days after notification thereof) which counsel
shall cooperate, and coordinate the defense, with the Company’s counsel and minimize the expense of such separate representation
to the extent consistent with the Executive’s separate defense. This Section 12 shall continue in effect after the termination
of the Executive’s employment or the termination of this Agreement

 

13.
Disputes.

 

(a)
Any dispute or controversy arising out of or relating to this Agreement or your employment shall be brought solely in the state
and federal courts located in the State and County of Pennsylvania.

 

(b)
BOTH THE COMPANY AND THE EXECUTIVE HEREBY WAIVE ANY RIGHT TO A TRIAL BY JURY TO THE MAXIMUM EXTENT PERMITTED BY APPLICABLE FEDERAL
OR STATE LAW.

 

(c)
In the event of any contest or dispute relating to this Agreement or the termination of Executive’s employment hereunder,
the non-prevailing party in any such contest or dispute shall be liable for the attorneys’ fees and costs of the prevailing
party.

 

    	9

    	 

    

 

14.
Integration. This Agreement constitutes the entire agreement between the parties with respect to the subject matter hereof
and supersedes all prior agreements between the parties concerning such subject matter.

 

15.
Successors. This Agreement shall inure to the benefit of and be enforceable by the Executive’s personal representatives,
executors, administrators, heirs, distributees, devisees and legatees. In the event of the Executive’s death after his termination
of employment but prior to the completion by the Company of all payments due him under this Agreement, the Company shall continue
such payments to the Executive’s beneficiary designated in writing to the Company prior to his death (or to his estate,
if the Executive fails to make such designation). The Company shall require any successor to the Company to expressly assume and
agree to perform this Agreement in the same manner and to the same extent that the Company would be required to perform it if
no such succession had taken place.

 

16.
Enforceability. If any portion or provision of this Agreement (including, without limitation, any portion or provision
of any section of this Agreement) shall to any extent be declared illegal or unenforceable by a court of competent jurisdiction,
then the remainder of this Agreement, or the application of such portion or provision in circumstances other than those as to
which it is so declared illegal or unenforceable, shall not be affected thereby, and each portion and provision of this Agreement
shall be valid and enforceable to the fullest extent permitted by law.

 

17.
Survival. The provisions of this Agreement shall survive the termination of this Agreement or the termination of the Executive’s
employment to the extent necessary to effectuate the terms contained herein.

 

18.
Waiver. No waiver of any provision hereof shall be effective unless made in writing and signed by the waiving party. The
failure of any party to require the performance of any term or obligation of this Agreement, or the waiver by any party of any
breach of this Agreement, shall not prevent any subsequent enforcement of such term or obligation or be deemed a waiver of any
subsequent breach.

 

19.
Notices. Any notices, requests, demands and other communications provided for by this Agreement shall be sufficient if
in writing and delivered in person or sent by a nationally recognized overnight courier service or by registered or certified
mail, postage prepaid, return receipt requested, to the Executive at the last address the Executive has filed in writing with
the Company or, in the case of the Company, at its main offices,

 

	 	If
    to Executive:	Christopher
    Ferguson
	 	 	258
    North West End Blvd 
	 	 	Suite 505
	 	 	Quakertown,
    PA 18951
	 	 	 
	 	If
    to Company:	Vinco
    Ventures, Inc.
	 	 	1
West Broad Street
	 	 	Suite 1004
	 	 	Bethlehem,
    PA 18018

 

20.
Amendment. This Agreement may be amended or modified only by a written instrument signed by the Executive and by a duly
authorized representative of the Company.

 

21.
Governing Law. This is a Pennsylvania contract and shall be construed under and be governed in all respects by the laws
of Pennsylvania for contracts to be performed in that State and without giving effect to the conflict of laws principles of Pennsylvania
or any other State.

 

22.
Counterparts. This Agreement may be executed in any number of counterparts, each of which when so executed and delivered
shall be taken to be an original; but such counterparts shall together constitute one and the same document.

 

[REMAINDER
OF THIS PAGE LEFT INTENTIONALLY BLANK]

 

    	10

    	 

    

 

IN
WITNESS WHEREOF, the parties have executed this Agreement effective on the date and year first above written.

 

	Vinco
    Ventures, Inc.	 
	 	 	 
	 	 
	By:	 	 
	Title:	           	 
	 	 	 
	Executive:	 
	 	 
	 	 
	Christopher
    Ferguson	 

 

    	11

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00320-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00320-of-00352.parquet"}]]